Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
NCT01595529Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2012
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cefixime, cefalexin, trimethoprim + sulfamethoxazole in urinary tract infection (UTI), sponsored by National Institute of Allergy and Infectious Diseases. Started May 2012; status: completed.
02
Drugs
cefiximecefalexintrimethoprim + sulfamethoxazole
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT01595529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595529.